Previous symbols: KGFR, BEK, CFD1, JWS. Aliases: CEK3, TK14, TK25, ECT1, K-SAM, CD332.
FGFR2 (Fibroblast Growth Factor Receptor 2) encodes a receptor tyrosine kinase that mediates FGF signaling in development, tissue repair, and homeostasis. CRITICAL ISOFORM BIOLOGY: Alternative splicing of exon IIIb vs IIIc in the third Ig-like domain creates isoforms with MUTUALLY EXCLUSIVE ligand specificities: (1) FGFR2IIIb (P21802-3, KGFR) is expressed in EPITHELIAL cells and binds FGF1, FGF3, FGF7 (KGF), and FGF10. FGF7 and FGF10 bind ONLY to IIIb. (2) FGFR2IIIc (P21802-1, BEK) is expressed in MESENCHYMAL cells and binds FGF1, FGF2, FGF4, FGF6, and FGF9. FGF2 binds preferentially to IIIc. This isoform switching enables PARACRINE signaling between epithelium and mesenchyme: mesenchyme produces FGF7/10 to signal to epithelial IIIb, while epithelium produces FGF2/4 to signal to mesenchymal IIIc. Critical for limb development, lung branching morphogenesis, and wound healing. Additional isoforms: Secreted/soluble forms (P21802-14, P21802-19) may act as decoy receptors. Numerous other splice variants exist with various domain combinations. Cancer relevance: IIIb-to-IIIc isoform switching accompanies epithelial-mesenchymal transition (EMT) and correlates with metastatic potential in some cancers.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Ameloblastoma | somatic driver somatic |
mechanism: Somatic RTK-RAS-MAPK Driver Alterations
|
| Antley-Bixler Syndrome, FGFR2-Related | causative germline |
mechanism: Extracellular FGFR2 Pathogenic Variants; Increased FGFR2 Kinase Activity
|
| Beare-Stevenson Cutis Gyrata Syndrome | causative germline |
mechanism: FGFR2 Activating Variant
|
| FGFR2-Related Bent Bone Dysplasia | causative germline |
mechanism: FGFR2 Transmembrane Polar Substitution
|
| Gastric Adenocarcinoma | somatic driver somatic |
mechanism: Receptor Tyrosine Kinase Amplification
scoped to subtype: CIN
|
| Pelvic Organ Prolapse | susceptibility | |
| Pfeiffer Syndrome | causative |
mechanism: FGFR2 gain-of-function signaling in cranial sutures
subtype: FGFR2-related
|
| Apert Syndrome |
untyped
Causative
|
mechanism: FGFR2 linker-region activating mutations
variant: p.Pro253Arg; p.Ser252Trp
animal model: Mouse
diagnosis: Molecular genetic testing for FGFR2 hotspot variants
|
| Congenital Pulmonary Airway Malformation |
untyped
Pathogenic Variants
somatic
|
|
| Crouzon Syndrome |
untyped
Pathogenic Variants
|
variant: p.Cys342Trp; p.Trp290Gly
|
| Humeroradial Synostosis |
untyped
Causative
|
|
| Jackson-Weiss Syndrome | no genetic record |
variant: p.Cys342Arg; p.Cys342Ser
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| Apert syndrome MONDO:0007041 | AD | Definitive 2021-12-14 |
Apert Syndrome
untyped
|
| Pfeiffer syndrome MONDO:0007043 | AD | Definitive 2022-03-21 |
Pfeiffer Syndrome
causative
|
| Crouzon syndrome MONDO:0007405 | AD | Definitive 2021-12-23 |
Crouzon Syndrome
untyped
|
| Beare-Stevenson cutis gyrata syndrome MONDO:0007412 | AD | Definitive 2022-03-31 |
Beare-Stevenson Cutis Gyrata Syndrome
causative
|
| LADD syndrome MONDO:0007872 | AD | Limited 2022-06-16 |
no dismech entry |
| bent bone dysplasia syndrome 1 MONDO:0013815 | AD | Definitive 2022-05-19 |
FGFR2-Related Bent Bone Dysplasia
causative
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.